The Belarusian vaccine received recognition at the international agricultural exhibition in Moscow.

As noted by Alexander Lyakhovsky, Director of the BioPharm Research Institute, the vaccine provides comprehensive protection for young animals against three dangerous diseases: rotavirus and coronavirus infections, as well as several pathogens that cause E. coli infection. The drug induces persistent colostral immunity in calves from the first days of life after feeding colostrum.

Three years of development culminated in successful implementation in industrial production. The vaccine's effectiveness has been recognized not only in Belarus but also among Russian veterinary specialists, who note its high efficiency. This success confirms the confidence of the international market, particularly the Russian Federation, in the quality and reliability of Belarusian biological products. Belarusian manufacturers offer a wide range of vaccines that protect animals from a variety of infections, but achieving maximum vaccination effectiveness requires strict adherence to animal husbandry practices.